The promise of thrombopoietins in the treatment of ITP.
Kuter
David J
DJ
D002352:Carrier Proteins / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000473:pathology; D011961:Receptors, Fc / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin / Q000627:therapeutic use*
D002352:Carrier Proteins; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim